2021 Annual Business Report

Our Marketing & Distribution Structure

Valneva has a specialist commercial infrastructure for the distribution of its travelers’ vaccines in key markets.

Our Marketing & Distribution Structure

The strength of an integrated business model

  • Based on 2021 product sales, Valneva managed 98% of its global product sales revenues through its own commercial operations. Local operations include expertise in Sales, Marketing, Medical Affairs, Government Affairs, business support functions and general management.
  • Valneva’s commercial teams work continuously to improve service and performance. We are embracing digital technology like eLearning, webinars, product and brand microsites and social media, as well as data analytics, which allow us to better connect with travelers, physicians and other health care professionals. Valneva puts the customer at the heart of its activities and focuses on their needs for improved awareness, a deeper understanding of the travel health landscape, and tailor-made services to achieve their objectives.
  • In 2021, Valneva also continued to leverage its commercial organization to distribute third-party products, such as Bavarian Nordic’s Rabipur®/RabAvert® and Encepur® vaccines commencing in certain territories. Through our partnership with Seqirus, we also continued to commercialize two differentiated flu vaccines in Austria.